Page last updated: 2024-12-05

methyl ricinoleate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

methyl ricinoleate: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5354133
CHEMBL ID3183150
CHEBI ID156194
SCHEMBL ID290360
MeSH IDM0046637

Synonyms (58)

Synonym
nsc-1254
ricinoleic acid methyl ester
methyl ricinolate
flexricin p-1
nsc1254
ricinoleic acid, methyl ester
methyl ricinoleate
141-24-2
methyl ricinoleate, >=99% (gc)
methyl (9z,12r)-12-hydroxyoctadec-9-enoate
9-octadecenoic acid, 12-hydroxy-, methyl ester, (9z,12r)-
methyl (z,12r)-12-hydroxyoctadec-9-enoate
CHEBI:156194
R0029
ricinolic acid methyl ester
NCGC00248854-01
9-octadecenoic acid, 12-hydroxy-, methyl ester, [r-(z)]-
tox21_200861
dtxcid509169
dtxsid2029169 ,
NCGC00258415-01
cas-141-24-2
9-octadecenoic acid, 12-hydroxy-, methyl ester, (r-(z))-
einecs 205-472-3
hsdb 5636
9-octadecenoic acid, 12-hydroxy-, methyl ester, (theta-(z))-
9-octadecenoic acid, 12-hydroxy-, methyl ester
nsc 1254
unii-90fdr3o96y
90fdr3o96y ,
12-hydroxy-9-octadecenoic acid, methyl ester
ai3-10523
methyl 12-d-hydroxy-9-cis-octadecenoate
cis-ricinoleic acid methyl ester
methyl ricinoleate [inci]
ricinic acid methyl ester
dub rm
ricinoleic acid, methyl ester [hsdb]
methyl ricinoleate [usp-rs]
SCHEMBL290360
methyl (9z)-12-hydroxy-9-octadecenoate #
CHEMBL3183150
mfcd00046712
methyl 12-hydroxyoleate
9-octadecenoic acid,12-hydroxy-, methyl ester, (9z,12r)-
methyl ricinoleate, analytical standard
AKOS027320383
AS-70362
methyl ricinoleate, european pharmacopoeia (ep) reference standard
ricinoleic acid-methyl ester
41989-07-5
methyl ricinoleate, united states pharmacopeia (usp) reference standard
(r,z)-methyl 12-hydroxyoctadec-9-enoate
12r-hydroxy-9-cis-octadecenoic acid methyl ester
methyl 12-hydroxy-9(z)-octadecenoate
Q27271321
CS-0139029
HY-N8045
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
aliphatic alcoholAn alcohol derived from an aliphatic compound.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (6)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency0.01220.006038.004119,952.5996AID1159521
GLI family zinc finger 3Homo sapiens (human)Potency30.76250.000714.592883.7951AID1259369
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency68.86870.003041.611522,387.1992AID1159553
retinoid X nuclear receptor alphaHomo sapiens (human)Potency55.21000.000817.505159.3239AID1159527
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency61.94660.001019.414170.9645AID743191
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency15.56030.057821.109761.2679AID1159526; AID1159528
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (22.73)18.2507
2000's10 (45.45)29.6817
2010's7 (31.82)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.55%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other21 (95.45%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]